Position in ABBV
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$18,683,766
-$1,689,827 QoQ
Shares Held
74,248
-20.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#638
of 4,153 holders
Holding Since
Mar 2021
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Y-Intercept (Hong Kong) Ltd holds $55,696,959 across 11 Drug Manufacturers - General names. ABBV ranks #1 (33.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
74,248 | $18,683,766 | |
| 2 | LLY |
ELI LILLY & Co
|
8,310 | $9,967,264 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
57,007 | $7,202,264 | |
| 4 | MRK |
Merck & Co., Inc.
|
51,433 | $6,609,140 | |
| 5 | NVO |
Novo Nordisk A S
|
86,018 | $4,123,702 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
46,615 | $2,685,956 | |
| 7 | AMGN |
Amgen Inc
|
5,281 | $1,912,355 | |
| 8 | GSK |
GSK plc
|
24,289 | $1,273,229 |
All Filings in ABBV
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,683,766 | 74,248 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $20,373,593 | 93,676 | Shares | Sole | 2026-04-27 | |
| 2025-03-31 | $1,938,269 | 9,251 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $875,883 | 4,929 | Shares | Sole | 2025-02-04 | |
| 2024-06-30 | $2,144,857 | 12,505 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $1,075,956 | 6,943 | Shares | Sole | 2024-02-13 | |
| 2023-06-30 | $4,552,391 | 33,789 | Shares | Sole | 2023-08-14 | |
| 2022-09-30 | $1,444,770 | 10,765 | Shares | Sole | 2023-02-14 | |
| 2021-06-30 | $432,875 | 3,843 | Shares | Sole | 2021-08-26 | |
| 2021-03-31 | $276,934 | 2,559 | Shares | Sole | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||